IRP2-Iron Axis Modulation to Reduce Ferroptotic Vulnerability

Target: IRP2-Iron Composite Score: 0.398 Price: $0.40 Citation Quality: Pending neurodegeneration Status: proposed

☰ Compare ⚔ Duel ⚛ Collideinteract with this hypothesis

✓ All Quality Gates Passed

Quality Report Card click to collapse

Composite: 0.398

Top 88% of 1402 hypotheses

T4 Speculative

Novel AI-generated, no external validation

Needs 1+ supporting citation to reach Provisional

D Mech. Plausibility 15% 0.35 Top 94%

C Evidence Strength 15% 0.48 Top 72%

B Novelty 12% 0.62 Top 71%

D Feasibility 12% 0.25 Top 94%

C Impact 12% 0.40 Top 93%

D Druggability 10% 0.28 Top 92%

C Safety Profile 8% 0.42 Top 78%

D Competition 6% 0.28 Top 98%

C Data Availability 5% 0.48 Top 77%

C Reproducibility 5% 0.42 Top 83%

Evidence

4 supporting | 4 opposing

Citation quality: 0%

Debates

1 session C+

Avg quality: 0.50

Convergence

0.00 F 30 related hypothesis share this target

From Analysis:

Microglial subtypes in neurodegeneration — friend vs foe

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflammatory) and their distinct roles in AD, PD, and ALS. Identify pharmacological targets for shifting microglia toward protective phenotypes.

→ View full analysis & debate transcript

Hypotheses from Same Analysis (6)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

TREM2-APOE Axis Manipulation via APOE Lipidation for DAM Recruitment

Score: 0.685 | Target: TREM2-APOE

CX3CL1-CX3CR1 Mimetic Therapy for Neuroprotection

Score: 0.635 | Target: CX3CL1-CX3CR1 Mimetic

CD38 Inhibition for NAD+ Restoration and Microglial Senescence Prevention

Score: 0.575 | Target: CD38

CSF1R Partial Agonism Combined with TREM2 Activation for ALS Neuroprotection

Score: 0.535 | Target: CSF1R Partial

ITGAX/CD11c Targeting to Eliminate Pro-inflammatory DAM in ALS

Score: 0.408 | Target: ITGAX/CD11c Targeting

PU.1 Degradation via PROTAC for Inflammatory Microglial Polarization

Score: 0.408 | Target: PU.1 Degradation via

→ View full analysis & all 7 hypotheses

Description

NOT RECOMMENDED. Contains a biochemical error that undermines the hypothesis. IREB2 binds to IRE sequences in the 5' UTR of FTH1 mRNA and REPRESSES FTH1 translation. Therefore, IREB2 deletion would INCREASE FTH1 expression—opposite of the hypothesis. FTH1 overexpression in AD microglia may represent a compensatory protective response (iron sequestration). Ferroptosis inhibitors (ferrostatin-1 analogs) failed in human trials. IREB2 is poorly druggable (requires ASO approach).

No AI visual card yet

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.

8 citations 8 with PMID Validation: 0% 4 supporting / 4 opposing

✓ For (4)

No supporting evidence

No opposing evidence

(4) Against ✗

High Medium Low

Evidence Matrix — sortable by strength/year, click Abstract to expand

Evidence Types

MECH 7CLIN 0GENE 1EPID 0

Claim	Stance	Category	Source	Strength ↕	Year ↕	Quality ↕	PMIDs	Abstract
IRP2 accumulates in microglia surrounding amyloid …	Supporting	MECH	-	-	-	-	PMID:29163160	-
FTH1 overexpression in AD microglia indicates iron…	Supporting	MECH	-	-	-	-	PMID:31201966	-
IREB2 deletion in mice reduces brain iron and impr…	Supporting	MECH	-	-	-	-	PMID:25416956	-
TREM2 deficiency exacerbates iron accumulation in …	Supporting	MECH	-	-	-	-	PMID:29900273	-
IREB2 binds 5' UTR IRE sequences and REPRESSE…	Opposing	MECH	-	-	-	-	PMID:Iron metabolism biochemistry	-
FTH1 overexpression may represent compensatory iro…	Opposing	MECH	-	-	-	-	PMID:31201966	-
Ferrostatin-1 analogs failed in human neurodegener…	Opposing	MECH	-	-	-	-	PMID:32877692	-
IREB2 knockout benefit may be due to neuronal iron…	Opposing	GENE	-	-	-	-	PMID:25416956	-

Legacy Card View — expandable citation cards

✓ Supporting Evidence 4

IRP2 accumulates in microglia surrounding amyloid plaques in AD brain

PMID:29163160

FTH1 overexpression in AD microglia indicates iron dysregulation and ferroptosis signature

PMID:31201966

IREB2 deletion in mice reduces brain iron and improves behavioral outcomes

PMID:25416956

TREM2 deficiency exacerbates iron accumulation in microglia

PMID:29900273

✗ Opposing Evidence 4

IREB2 binds 5' UTR IRE sequences and REPRESSES FTH1 translation—IREB2 deletion would INCREASE FTH1

PMID:Iron metabolism biochemistry

FTH1 overexpression may represent compensatory iron sequestration—reducing FTH1 could paradoxically increase o…▼

FTH1 overexpression may represent compensatory iron sequestration—reducing FTH1 could paradoxically increase oxidative stress

PMID:31201966

Ferrostatin-1 analogs failed in human neurodegenerative disease trials

PMID:32877692

IREB2 knockout benefit may be due to neuronal iron deficiency, not microglial effects

PMID:25416956

Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.

Gap Analysis | 4 rounds | 2026-04-18 | View Analysis

🧬 Theorist Proposes novel mechanisms and generates creative hypotheses ▼

Therapeutic Hypotheses: Microglial Subtype Reprogramming in Neurodegeneration

Hypothesis 1: TREM2-APOE Axis Manipulation via APOE Sylation to Recruit Protective DAM in AD

Description: APOE4 impairs TREM2-dependent microglial clustering around amyloid plaques by disrupting lipid efflux pathways. Enhancing APOE lipidation through ABCA1 activation or inhibiting APOE fragmentation (by targeting cathepsin D) will restore TREM2-APOE signaling, promoting protective DAM recruitment to amyloid and increasing phagocytic clearance without driving neurotoxic inflammation.

**Target Gene/

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns ▼

Critical Evaluation of Microglial Subtype Reprogramming Hypotheses

Hypothesis 1: TREM2-APOE Axis Manipulation via APOE Sylation

Weaknesses in Evidence

Mechanistic Assumptions:
The hypothesis conflates correlation with causation regarding APOE4's effect on TREM2-dependent microglial function. The cited evidence (PMID:28445323) demonstrates TREM2 R47H impairs plaque localization, but this variant is distinct from APOE4 effects—APOE4 may influence microglial function through APOE-independent mechanisms.

APOE Fragmentation Complexity:
The assumption that cathepsin D inhibiti

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation ▼

Critical Evaluation: Microglial Subtype Reprogramming Hypotheses

Practical Drug Development Assessment

Hypothesis 1: APOE Lipidation for DAM Recruitment

Target Druggability & Chemical Matter

ABCA1 (Strong tractability):

ABCA1 is a well-validated enzyme with clear substrate binding domains
Tool compounds: GW3965 (LXR agonist, Bristol-Myers Squibb), CS-6253 (ABCA1 agonist, scripps) — both increase ABCA1 expression
Failed programs: CSK-925323 (Pfizer) discontinued after hepatotoxicity signal from LXR-driven lipogenesis
Current clinical candidates: No

⚖ Synthesizer Integrates perspectives and produces final ranked assessments ▼

Price History

7d Trend

↔

Stable

7d Momentum

▲ 0.0%

Volatility

Low

0.0000

Events (7d)

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (6)

Paper:25416956

No extracted figures yet

Paper:29163160

No extracted figures yet

Paper:29900273

No extracted figures yet

Paper:31201966

No extracted figures yet

Paper:32877692

No extracted figures yet

Paper:Iron metabolism biochemistry

No extracted figures yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (1)

📓 Microglial subtypes in neurodegeneration — friend vs foe — Analysis Notebook

→ Browse all notebooks

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas

→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score

0.50

31.7th percentile (747 hypotheses)

Tokens Used

KG Edges Generated

Citations Produced

Cost Ratios

Cost per KG Edge

0.00 tokens

Lower is better (baseline: 2000)

Cost per Citation

0.00 tokens

Lower is better (baseline: 1000)

Cost per Score Point

0.00 tokens

Tokens / composite_score

Score Impact

Efficiency Boost to Composite

+0.050

10% weight of efficiency score

Adjusted Composite

0.448

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

KG Entities (20)

ABCA1 APOE APOE4 CD38 CSF1R CX3CL1 CX3CR1 DAM subset FTH1 IREB2/IRP2 ITGAX/CD11c NAD+NLRP3 inflammasome P2Y12 SPI1/PU.1 TREM2 TREM2-dependent clustering TYROBP iron accumulation microglial survival

Related Hypotheses

LPS-TLR4-NF-κB Signaling Cascade as Therapeutic Target

Score: 7.200 | neurodegeneration

Enteric Nervous System Dysfunction as Self-Reinforcing Pathological Loop

Score: 7.000 | neurodegeneration

Vagus Nerve as Anatomical Highway for Prion-Like α-Syn Propagation

Score: 6.000 | neurodegeneration

SCFA Deficiency Disrupts Microglial Homeostasis and Promotes Neurodegeneration

Score: 5.500 | neurodegeneration

TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegeneration

Score: 0.990 | neurodegeneration

Estimated Development

Estimated Cost

Timeline

0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (12 edges)

Mechanism Pathway for IRP2-Iron

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    TREM2["TREM2"] -->|signals through| TYROBP["TYROBP"]
    APOE4["APOE4"] -->|impairs| TREM2_dependent_clusterin["TREM2-dependent clustering"]
    ABCA1["ABCA1"] -->|lipidates| APOE["APOE"]
    CX3CR1["CX3CR1"] -.->|suppresses| NLRP3_inflammasome["NLRP3 inflammasome"]
    CX3CR1_1["CX3CR1"] -->|regulates| P2Y12["P2Y12"]
    CD38["CD38"] -->|depletes| NAD_["NAD+"]
    CSF1R["CSF1R"] -->|maintains| microglial_survival["microglial survival"]
    SPI1_PU_1["SPI1/PU.1"] -->|regulates| TREM2_2["TREM2"]
    IREB2_IRP2["IREB2/IRP2"] -->|represses| FTH1["FTH1"]
    ITGAX_CD11c["ITGAX/CD11c"] -->|marks| DAM_subset["DAM subset"]
    TREM2_3["TREM2"] -->|coordinates| iron_accumulation["iron accumulation"]
    CX3CL1["CX3CL1"] -->|engages| CX3CR1_4["CX3CR1"]
    style TREM2 fill:#ce93d8,stroke:#333,color:#000
    style TYROBP fill:#ce93d8,stroke:#333,color:#000
    style APOE4 fill:#ce93d8,stroke:#333,color:#000
    style TREM2_dependent_clusterin fill:#4fc3f7,stroke:#333,color:#000
    style ABCA1 fill:#ce93d8,stroke:#333,color:#000
    style APOE fill:#ce93d8,stroke:#333,color:#000
    style CX3CR1 fill:#ce93d8,stroke:#333,color:#000
    style NLRP3_inflammasome fill:#4fc3f7,stroke:#333,color:#000
    style CX3CR1_1 fill:#ce93d8,stroke:#333,color:#000
    style P2Y12 fill:#ce93d8,stroke:#333,color:#000
    style CD38 fill:#ce93d8,stroke:#333,color:#000
    style NAD_ fill:#ce93d8,stroke:#333,color:#000
    style CSF1R fill:#ce93d8,stroke:#333,color:#000
    style microglial_survival fill:#4fc3f7,stroke:#333,color:#000
    style SPI1_PU_1 fill:#4fc3f7,stroke:#333,color:#000
    style TREM2_2 fill:#ce93d8,stroke:#333,color:#000
    style IREB2_IRP2 fill:#ce93d8,stroke:#333,color:#000
    style FTH1 fill:#ce93d8,stroke:#333,color:#000
    style ITGAX_CD11c fill:#ce93d8,stroke:#333,color:#000
    style DAM_subset fill:#4fc3f7,stroke:#333,color:#000
    style TREM2_3 fill:#ce93d8,stroke:#333,color:#000
    style iron_accumulation fill:#4fc3f7,stroke:#333,color:#000
    style CX3CL1 fill:#ce93d8,stroke:#333,color:#000
    style CX3CR1_4 fill:#ce93d8,stroke:#333,color:#000

3D Protein Structure

🧬 IRP2-IRON — Search for structure Click to search RCSB PDB

🔍 Searching RCSB PDB for IRP2-IRON structures...

Querying Protein Data Bank API

Source Analysis

Microglial subtypes in neurodegeneration — friend vs foe

neurodegeneration | 2026-04-17 | completed

Community Feedback

0 0 upvotes · 0 downvotes

💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

IRP2-Iron Axis Modulation to Reduce Ferroptotic Vulnerability

Hypotheses from Same Analysis (6)

Description

Dimension Scores

✓ Supporting Evidence 4

✗ Opposing Evidence 4

Therapeutic Hypotheses: Microglial Subtype Reprogramming in Neurodegeneration

Hypothesis 1: TREM2-APOE Axis Manipulation via APOE Sylation to Recruit Protective DAM in AD

Critical Evaluation of Microglial Subtype Reprogramming Hypotheses

Hypothesis 1: TREM2-APOE Axis Manipulation via APOE Sylation

Weaknesses in Evidence

Critical Evaluation: Microglial Subtype Reprogramming Hypotheses

Practical Drug Development Assessment

Hypothesis 1: APOE Lipidation for DAM Recruitment

Target Druggability & Chemical Matter

Price History

Clinical Trials (0)

📚 Cited Papers (6)

📙 Related Wiki Pages (0)

📓 Linked Notebooks (1)

⚔ Arena Performance

🔄 Related Hypotheses

Hypotheses from Same Analysis (6)

🧬 Same Target Gene / Disease (30)

📊 Resource Economics & ROI

Cost Ratios

Score Impact

How Economics Pricing Works

KG Entities (20)

Related Hypotheses

Estimated Development

🧪 Falsifiable Predictions

Knowledge Subgraph (12 edges)

coordinates (1)

depletes (1)

engages (1)

impairs (1)

lipidates (1)

maintains (1)

marks (1)

regulates (2)

represses (1)

signals through (1)

suppresses (1)

Mechanism Pathway for IRP2-Iron

3D Protein Structure

Source Analysis

Microglial subtypes in neurodegeneration — friend vs foe

Community Feedback